XBIT XBiotech Inc.: Accounting Value per Share

Public company logo of XBiotech Inc. (XBIT)

XBiotech Inc. relies on a strong team of biochemists who have maintained the stability of the R&D unit. The price action of the book value per share clearly confirms this potential, while the 4.20 value reflects the current magnitude of accumulated assets. However, intense competition from pharma behemoths and the risks of delays in new drug registrations exert significant pressure on the business's final margins.

XBiotech USA (XBIT) - Accounting Value per Share from 07/04/2022 to 10/27/2026

Summary analytical data breakdowns for XBiotech Inc (XBIT)

- price and consensus price forecast:
Stock Price XBiotech USA|XBIT - Analyst Median Target
- market capitalization data:
Market Valuation XBiotech Inc.|XBIT - Aggregate Business Value
- book capitalization data:
Book Value per Share XBiotech|XBIT - Company Net Assets|Market Capitalization to Book Value Ratio xbiotech.com|XBIT - Company Total Assets
- debt and liquidity data:
Debt to Equity XBiotech Inc.|XBIT - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital XBiotech USA|XBIT - Company Total Debt|Debts to Book Capitalization XBiotech Inc.
Analysis of all company metrics:xbiotech.com, XBIT
Manufactured product of XBiotech Inc

The net equity dynamics of XBiotech Inc. (XBIT), safeguarded by strict bioethics and ESG waste disposal standards, minimize risks during market volatility. An analysis of the capital per share allows for the separation of real internal asset accumulation from speculative price fluctuations, where an upward trend confirms growth in fundamental value, while stagnation without payouts signals a risk of inefficient resource utilization.

Competitor analysis for XBiotech Inc.

Book Value per Share ONC (BeiGene Corp)|Halozyme Corp (HALO) - Net Assets per Share|RVMD - Accounting Value per Share|ascentage.com (AAPG) - Book Price of a Share|Book Value per Share CGON|Accounting Value per Share UroGen Pharma Ltd|Book Value per Share BCAX|Book Value per Share PSNL (Personalis Genomics)|ERAS - Net Assets per Single Share|Equity per Share delcath.com DCTH|YMAB: Book Value per Share|AURA - Accounting Value per Share|Book Value per Share CADL|ARAY (Accuray, Inc.) - Net Asset Value per Share|SLS - Net Assets per Single Share|Accounting Value of a Share actuatetherapeutics.com (ACTU)|Citius Oncology (CTOR) - Accounting Value per Share|Accounting Value of a Share tuhurabio.com (HURA)|Protara - Book Value per Share|FATE - Accounting Value per Share|Aadi Bio - Accounting Value per Share|TCRX: Book Value per Share|Net Assets per Single Share championsoncology.com CSBR|CEL-SCI (CVM) - Accounting Value of a Share|Book Value per Share OSTX (OS Therapies Inc)|Net Asset Value per Share radiopharmtheranostics.com (RADX)|Accounting Value per Share Artiva Biotherapeutics, Inc. ARTV|Equity per Share adlainortye.com (ANL)|Book Value per Share Veru VERU|Net Assets per Single Share Tempest Therapeutics Inc TPST|Book Value per Share XLO (Xilio)|RENB: Net Assets per Share|Net Assets per Single Share MURA|Net Asset Value per Share Kairos Pharma|OnKure Therapeutics, Inc. (OKUR) - Accounting Value per Share|Book Price of a Share CytoMed|Curis, Inc. - Book Value per Share|Net Asset Value per Share apollomicsinc.com (APLM)|Tharimmune, Inc. - Book Value per Share|Accounting Value per Share Advanced Biomed Inc. ADVB|Book Value per Share Genprex (GNPX)|Calidi Biotherapeutics (CLDI) - Accounting Value of a Share|Accounting Value per Share Sunshine Biopharma, Inc. SBFM|Xenetic Biosciences, Inc. (XBIO) - Accounting Value of a Share|SLRX: Book Value per Share|Net Assets per Share PPBT|Net Assets per Single Share American Oncology Network AONC|Equity per Share BeiGene Ltd. (BGNE)|Checkpoint Therapeutics, Inc - Book Value per Share|ELEV - Accounting Value per Share|Accounting Value per Share ICAD (iCAD Corp)|Ikena Oncology, Inc. (IKNA) - Net Assets per Share|Accounting Value per Share Notable Labs|Viracta Therapeutics, Inc. (VIRX) - Equity per Share|Book Value per Share MorphoSys Corp|Net Assets per Single Share NAYA Biosciences Corp|AAPGV (Ascentage Pharma Group) - Book Value per Share